Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Siegert

Showing results (171-180 of 209) with videos related to

Pageof 21
Sort By:
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Accidental overdose of mitoxantrone in three patientsW Siegert, W Hiddemann, R Koppensteiner, et al.
Bone Marrow Transplantation|November 13, 2001
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndromeN Kröger, J Schetelig, T Zabelina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study GroupW Siegert, J Beyer, I Strohscheer, et al.
Medical and Pediatric Oncology|January 1, 1994
High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastomaB Kremens, T Klingebiel, F Herrmann, et al.
Bone Marrow Transplantation|May 1, 1996
Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3W E Aulitzky, A Neubauer, K Kolbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceU De Giorgi, T Demirer, H Wandt, et al.
Vox Sanguinis|January 1, 1994
Microbiologic contamination of peripheral blood stem cell autograftsN Schwella, R Zimmermann, H G Heuft, et al.
Onkologie|February 1, 1989
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study]H H Gerhartz, W Wilmanns, G Brittinger, et al.
International Journal of Cancer|May 8, 2000
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patientsK A Kreuzer, U Lass, S Nagel, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Pageof 21

Showing results (171-180 of 209) with videos related to

Sort By:
Pageof 21
Medical Oncology and Tumor Pharmacotherapy|January 1, 1989
Accidental overdose of mitoxantrone in three patientsW Siegert, W Hiddemann, R Koppensteiner, et al.
Bone Marrow Transplantation|November 13, 2001
A fludarabine-based dose-reduced conditioning regimen followed by allogeneic stem cell transplantation from related or unrelated donors in patients with myelodysplastic syndromeN Kröger, J Schetelig, T Zabelina, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1994
High-dose treatment with carboplatin, etoposide, and ifosfamide followed by autologous stem-cell transplantation in relapsed or refractory germ cell cancer: a phase I/II study. The German Testicular Cancer Cooperative Study GroupW Siegert, J Beyer, I Strohscheer, et al.
Medical and Pediatric Oncology|January 1, 1994
High-dose consolidation with local radiation and bone marrow rescue in patients with advanced neuroblastomaB Kremens, T Klingebiel, F Herrmann, et al.
Bone Marrow Transplantation|May 1, 1996
Preliminary results of stem cell mobilization in chronic myeloid leukemia with a moderate intensity chemotherapy regimen and G-CSF or G-CSF plus IL-3W E Aulitzky, A Neubauer, K Kolbe, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 16, 2004
Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experienceU De Giorgi, T Demirer, H Wandt, et al.
Vox Sanguinis|January 1, 1994
Microbiologic contamination of peripheral blood stem cell autograftsN Schwella, R Zimmermann, H G Heuft, et al.
Onkologie|February 1, 1989
[Risk-adapted therapy of highly malignant non-Hodgkin's lymphomas with COP-BLAM/IMVP-16: a prospective multicenter study]H H Gerhartz, W Wilmanns, G Brittinger, et al.
International Journal of Cancer|May 8, 2000
Applicability of an absolute quantitative procedure to monitor intra-individual bcr/abl transcript kinetics in clinical samples from chronic myelogenous leukemia patientsK A Kreuzer, U Lass, S Nagel, et al.
Blood|October 15, 1993
Randomized, double-blind, placebo-controlled, phase III study of recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to induction treatment of high-grade malignant non-Hodgkin's lymphomasH H Gerhartz, M Engelhard, P Meusers, et al.
Pageof 21